Evidence map›Paper›PMID 23209804›Full record

ArticlePloS one2012

Molecular evolution of hemagglutinin (H) gene in measles virus genotypes D3, D5, D9, and H1.

Mika Saitoh, Makoto Takeda, Koichi Gotoh, Fumihiko Takeuchi, Tsuyoshi Sekizuka, Makoto Kuroda, Katsumi Mizuta, Akihide Ryo, Ryota Tanaka, Haruyuki Ishii and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Vaccine chronicle in Japan.Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Mika SaitohGunma Prefectural Institute of Public Health and Environmental Sciences, Maebashi-shi, Gunma, Japan.
Makoto Takeda
Koichi Gotoh
Fumihiko Takeuchi
Tsuyoshi Sekizuka
Makoto Kuroda
Katsumi Mizuta
Akihide Ryo
Ryota Tanaka
Haruyuki Ishii
Hayato Takada
Kunihisa Kozawa
Ayako Yoshida
Masahiro Noda
Nobuhiko Okabe
Hirokazu Kimura
National Institute of Infectious Diseases · JPGunma Prefectural Institute of Public Health and Environmental Sciences · JPKyorin University · JPAomori Public University · JPYamagata Prefectural Institute of Public Health · JPYokohama City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We studied the molecular evolution of H gene in four prevalent Asian genotypes (D3, D5, D9, and H1) of measles virus (MeV). We estimated the evolutionary time scale of the gene by the bayesian Markov Chain Monte Carlo (MCMC) method. In addition, we predicted the changes in structure of H protein due to selective pressures. The phylogenetic tree showed that the first division of these genotypes occurred around 1931, and further division of each type in the 1960-1970s resulted in four genotypes. The rate of molecular evolution was relatively slow (5.57×10(-4) substitutions per site per year). Only two positively selected sites (F476L and Q575K) were identified in H protein, although these substitutions might not have imparted significant changes to the structure of the protein or the epitopes for phylactic antibodies. The results suggested that the prevalent Asian MeV genotypes were generated over approximately 30-40 years and H protein was well conserved.

Indexed as

Evolution, MolecularGenotypeHemagglutininsMeasles virusViral ProteinsHemagglutininsViral Proteins

Identifiers

PMID23209804
PMCPMC3510160
OpenAlexW1970287151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.